Effectively translating the language of science to investors and the language of investing to scientists. With a decade of experience working as a scientist in venture development and venture capital, Dr. Carol Curtis is highly skilled and capable of evaluating technologies for merit AND investment potential. In the past 5 years, Dr. Curtis has provided business advice to more than 30 companies across multiple life science and tech-based industries and has evaluated more than 70 companies for investment potential. Of these, 18 companies ultimately received investment through venture investment rounds totaling more than $46 million. Dr. Curtis has a unique ability to communicate difficult concepts – from molecular biology to term sheet conditions – in a way that is easy to understand. With a critical mindset that is focused on achieving value for all clients, Dr. Curtis provides clarity and detail to a diligence process that can be frustrating and time consuming for both the company seeking capital and the investor seeking investable deals. C^2 Consulting offers: Services for scientists, universities and entrepreneurs - · Advising on the commercialization and/or regulatory path for new technologies and products · Organizing and preparing materials for fundraising · Building a data room and facilitating effective communications with potential investors Services for angel investors, VCs and family offices - · Evaluating new technologies for merit and market acceptance · Performing a deep dive diligence review for investment consideration · Managing portfolio company operations and/or performance
